187 related articles for article (PubMed ID: 9477096)
1. Determination of pancreatic ductal carcinoma histogenesis by analysis of mucous quality and K-ras mutation.
Matsubayashi H; Watanabe H; Nishikura K; Ajioka Y; Kijima H; Saito T
Cancer; 1998 Feb; 82(4):651-60. PubMed ID: 9477096
[TBL] [Abstract][Full Text] [Related]
2. Multiple K-ras mutations in hyperplasia and carcinoma in cases of human pancreatic carcinoma.
Matsubayashi H; Watanabe H; Yamaguchi T; Ajioka Y; Nishikura K; Iwafuchi M; Yamano M; Kijima H; Saito T
Jpn J Cancer Res; 1999 Aug; 90(8):841-8. PubMed ID: 10543256
[TBL] [Abstract][Full Text] [Related]
3. Different amounts of K-ras mutant epithelial cells in pancreatic carcinoma and mass-forming pancreatitis.
Matsubayashi H; Watanabe H; Ajioka Y; Nishikura K; Yamano M; Seki T; Saito T; Matsubayashi T
Pancreas; 2000 Jul; 21(1):77-85. PubMed ID: 10881936
[TBL] [Abstract][Full Text] [Related]
4. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma.
DiGiuseppe JA; Hruban RH; Offerhaus GJ; Clement MJ; van den Berg FM; Cameron JL; van Mansfeld AD
Am J Pathol; 1994 May; 144(5):889-95. PubMed ID: 8178941
[TBL] [Abstract][Full Text] [Related]
5. High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters.
Sugio K; Gazdar AF; Albores-Saavedra J; Kokkinakis DM
Carcinogenesis; 1996 Feb; 17(2):303-9. PubMed ID: 8625455
[TBL] [Abstract][Full Text] [Related]
6. The role of p21ras in pancreatic neoplasia and chronic pancreatitis.
Mulligan NJ; Yang S; Andry C; Klein M; O'Brien MJ
Hum Pathol; 1999 Jun; 30(6):602-10. PubMed ID: 10374765
[TBL] [Abstract][Full Text] [Related]
7. Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status.
Berger DH; Chang H; Wood M; Huang L; Heath CW; Lehman T; Ruggeri BA
Cancer; 1999 Jan; 85(2):326-32. PubMed ID: 10023699
[TBL] [Abstract][Full Text] [Related]
8. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
[TBL] [Abstract][Full Text] [Related]
9. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
[TBL] [Abstract][Full Text] [Related]
10. Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas.
Izawa T; Obara T; Tanno S; Mizukami Y; Yanagawa N; Kohgo Y
Cancer; 2001 Oct; 92(7):1807-17. PubMed ID: 11745253
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas.
Z'graggen K; Rivera JA; Compton CC; Pins M; Werner J; Fernández-del Castillo C; Rattner DW; Lewandrowski KB; Rustgi AK; Warshaw AL
Ann Surg; 1997 Oct; 226(4):491-8; discussion 498-500. PubMed ID: 9351717
[TBL] [Abstract][Full Text] [Related]
12. A two-step enriched-nested PCR technique enhances sensitivity for detection of codon 12 K-ras mutations in pancreatic adenocarcinoma.
Banerjee SK; Makdisi WF; Weston AP; Campbell DR
Pancreas; 1997 Jul; 15(1):16-24. PubMed ID: 9211488
[TBL] [Abstract][Full Text] [Related]
13. K-ras mutations and allelic loss at 5q and 18q in the development of human pancreatic cancers.
Sugio K; Molberg K; Albores-Saavedra J; Virmani AK; Kishimoto Y; Gazdar AF
Int J Pancreatol; 1997 Jun; 21(3):205-17. PubMed ID: 9322119
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic carcinomas of acinar and mixed acinar/ductal phenotypes in Ela-1-myc transgenic mice do not contain c-K-ras mutations.
Schaeffer BK; Terhune PG; Longnecker DS
Am J Pathol; 1994 Sep; 145(3):696-701. PubMed ID: 8080049
[TBL] [Abstract][Full Text] [Related]
15. Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distribution.
Lüttges J; Reinecke-Lüthge A; Möllmann B; Menke MA; Clemens A; Klimpfinger M; Sipos B; Klöppel G
Virchows Arch; 1999 Nov; 435(5):461-8. PubMed ID: 10592048
[TBL] [Abstract][Full Text] [Related]
16. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
[TBL] [Abstract][Full Text] [Related]
17. Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53.
Lüttges J; Diederichs A; Menke MA; Vogel I; Kremer B; Klöppel G
Cancer; 2000 Jun; 88(11):2495-504. PubMed ID: 10861425
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
19. Foamy gland pattern of pancreatic ductal adenocarcinoma: a deceptively benign-appearing variant.
Adsay V; Logani S; Sarkar F; Crissman J; Vaitkevicius V
Am J Surg Pathol; 2000 Apr; 24(4):493-504. PubMed ID: 10757396
[TBL] [Abstract][Full Text] [Related]
20. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy.
Jimenez RE; Warshaw AL; Z'graggen K; Hartwig W; Taylor DZ; Compton CC; Fernández-del Castillo C
Ann Surg; 1999 Oct; 230(4):501-9; discussion 509-11. PubMed ID: 10522720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
